Cadence Biomedical Closes $1.1M Series A2 Financing
Cadence Biomedical, a Seattle, WA-based medical device company, closed a $1.1m Series A2 financing.
The round was led by HealthTech Capital, with participation from Sand Hill Angels, Tech Coast Angels, ACE Fund, Frontier Angel Fund, WINGS, Alliance of Angels, and Keiretsu Forum Northwest.
The company intends to use the financing for manufacturing and sales as it releases its Kickstart™ Kinetic Orthosis to the market.
Led by CEO Brian Glaister, Cadence Biomedical focuses on providing medical devices that help people with severe disabilities walk. Its new class of device, Kinetic Orthosis, provides stability and movement assistance to weakened muscles without the use of powered mechanisms. Kickstart uses a proprietary tuned system of pulleys and springs that captures energy during the beginning of a step and then returns it at the right moment to help propel the user forward and lift the leg in preparation for the next step.